Immune Reconstitution Syndrome: Clinical Trials

2 trials for Immune Reconstitution Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 31Withdrawn 1

Follow Immune Reconstitution Syndrome: new trials by email Literature Review of Immune Reconstitution Syndrome trials Research Report on Immune Reconstitution Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
Valganciclovir, Antiretroviral Combinations - Kaposi Sarcoma, Human Immunodeficiency Virus
Phase 2CompletedNational Institute of Cancerología402015-10-012022-01-27
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Dexamethasone, Atorvastatin, Naproxen - Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome
Phase 2 / Phase 3WithdrawnUniversity of Minnesota2014-01-012013-11-25

Narrower conditions

Acquired Immunodeficiency Syndrome (2)  ·  Immune Reconstitution Inflammatory Syndrome (2)  ·  Sarcoma, Kaposi (1)  ·  Tuberculosis (1)

Broader conditions

Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  HIV Infections (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Lentivirus Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Sexually Transmitted Diseases (2)  ·  Sexually Transmitted Diseases, Viral (2)  ·  Slow Virus Diseases (2)  ·  Urogenital Diseases (2)  ·  Virus Diseases (2)

Interventions

Atorvastatin (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Naproxen (1)  ·  Valganciclovir (1)

Sponsors

National Institute of Cancerología (1)  ·  University of Minnesota (1)

Countries

Mexico (1)  ·  Thailand (1)

Top investigators

David R Boulware, MD, MPH (1)  ·  Sasisopin Kiertiburanakul, MD, MHS (1)  ·  Ubonvan Jongwutiwes, MD (1)

Results publications

PMID 32493198